Valeo Pharma Inc
TSX:VPH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Valeo Pharma Inc
Valeo Pharma Inc
Cash & Cash Equivalents
Valeo Pharma Inc
Cash & Cash Equivalents Peer Comparison
TH
EDT
CPH
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Valeo Pharma Inc
TSX:VPH
|
Cash & Cash Equivalents
CA$7.5m
|
CAGR 3-Years
38%
|
CAGR 5-Years
266%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Cash & Cash Equivalents
$38.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
69%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash & Cash Equivalents
CA$62.8m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash & Cash Equivalents
CA$2.1m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-6%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Cash & Cash Equivalents
$42m
|
CAGR 3-Years
47%
|
CAGR 5-Years
40%
|
CAGR 10-Years
3%
|
|
V
|
Vext Science Inc
CNSX:VEXT
|
Cash & Cash Equivalents
$8.7m
|
CAGR 3-Years
71%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
See Also
What is Valeo Pharma Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
7.5m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Cash & Cash Equivalents amounts to 7.5m CAD.
What is Valeo Pharma Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
266%
Over the last year, the Cash & Cash Equivalents growth was -67%. The average annual Cash & Cash Equivalents growth rates for Valeo Pharma Inc have been 38% over the past three years , 266% over the past five years .
You don't have any saved screeners yet
